Lois E Lamerato

Summary

Affiliation: Henry Ford Hospital
Country: USA

Publications

  1. pmc Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, Monkton, MD 21111, USA
    BMC Nephrol 13:5. 2012
  2. ncbi request reprint Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data
    Lois Lamerato
    Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan 48105, USA
    Cancer 106:1875-82. 2006
  3. doi request reprint Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System
    Lois E Lamerato
    Department of Biostatistics and Research Epidemiology, Henry Ford Health System, One Ford Place 5C, Detroit, MI 48125, USA
    Cancer Epidemiol Biomarkers Prev 17:827-33. 2008
  4. ncbi request reprint The economic impact of false-positive cancer screens
    Jennifer Elston Lafata
    Center for Health Services Research, Henry Ford Health System, 1 Ford Place, 3A, Detroit, MI 48202, USA
    Cancer Epidemiol Biomarkers Prev 13:2126-32. 2004
  5. ncbi request reprint Routine surveillance care after cancer treatment with curative intent
    Jennifer Elston Lafata
    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
    Med Care 43:592-9. 2005
  6. doi request reprint Risk for renal cell carcinoma in chronic hepatitis C infection
    Stuart C Gordon
    Division of Gastroenterology and Hepatology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA
    Cancer Epidemiol Biomarkers Prev 19:1066-73. 2010
  7. doi request reprint Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia
    Nadia Z Haque
    Infectious Diseases, Wayne State University School of Medicine, Henry Ford Health System, Detroit, MI 48202, USA
    Chest 138:1356-62. 2010
  8. ncbi request reprint Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network
    Erin J Aiello
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Breast Cancer Res Treat 107:397-403. 2008

Collaborators

Detail Information

Publications8

  1. pmc Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, Monkton, MD 21111, USA
    BMC Nephrol 13:5. 2012
    ..This study describes the proportion of patients transfused, units of blood transfused and trigger-hemoglobin (Hb) levels for transfusions in severe anemic, ND-CKD patients in routine practice...
  2. ncbi request reprint Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data
    Lois Lamerato
    Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan 48105, USA
    Cancer 106:1875-82. 2006
    ..The economics of breast cancer recurrence are poorly understood. For this retrospective cohort study, the authors evaluated the economic burden of breast cancer recurrence by using data from a large Midwestern healthcare system...
  3. doi request reprint Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System
    Lois E Lamerato
    Department of Biostatistics and Research Epidemiology, Henry Ford Health System, One Ford Place 5C, Detroit, MI 48125, USA
    Cancer Epidemiol Biomarkers Prev 17:827-33. 2008
    ....
  4. ncbi request reprint The economic impact of false-positive cancer screens
    Jennifer Elston Lafata
    Center for Health Services Research, Henry Ford Health System, 1 Ford Place, 3A, Detroit, MI 48202, USA
    Cancer Epidemiol Biomarkers Prev 13:2126-32. 2004
    ..We evaluated the medical and nonmedical costs associated with false-positive prostate, lung, colorectal, and ovarian cancer screens...
  5. ncbi request reprint Routine surveillance care after cancer treatment with curative intent
    Jennifer Elston Lafata
    Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
    Med Care 43:592-9. 2005
    ..Many consensus guidelines recommend routine surveillance to detect recurrent disease among cancer survivors. We compare surveillance care receipt to guideline recommendations...
  6. doi request reprint Risk for renal cell carcinoma in chronic hepatitis C infection
    Stuart C Gordon
    Division of Gastroenterology and Hepatology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA
    Cancer Epidemiol Biomarkers Prev 19:1066-73. 2010
    ..We sought to determine whether HCV infection confers an increased risk for developing RCC...
  7. doi request reprint Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia
    Nadia Z Haque
    Infectious Diseases, Wayne State University School of Medicine, Henry Ford Health System, Detroit, MI 48202, USA
    Chest 138:1356-62. 2010
    ..These infections are associated with significant morbidity, mortality, and cost. The impact of vancomycin minimum inhibitory concentration (MIC) on mortality for patients with MRSA pneumonia has not been determined...
  8. ncbi request reprint Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network
    Erin J Aiello
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Breast Cancer Res Treat 107:397-403. 2008
    ..We evaluated diffusion of aromatase inhibitor dispensings for breast cancer treatment in integrated healthcare delivery systems across the United States...